ArticlePLOS global public health2024

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Catherine Riou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.